ACUMEN PHARMACEUTICALS INC. - COMMON STOCK
1.7950
24-December-24 12:43:17
15 minutes delayed
Stocks
+0.0250
+1.41%
Today's range
1.7300 - 1.8300
ISIN
N/A
Source
NASDAQ
-
08 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024
07 May 2024 16:00:00 By Nasdaq GlobeNewswire
-
16 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
04 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
-
26 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
19 Mar 2024 16:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days
12 Mar 2024 16:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer
01 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 16:15:20 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights
13 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals Secures $50.0 Million Credit Facility with K2 HealthVentures
13 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference
07 Nov 2023 16:01:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Report Third Quarter Financial Results on November 13, 2023
06 Nov 2023 16:01:00 By Nasdaq GlobeNewswire
-
06 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
Acumen Pharmaceuticals to Participate in the UBS Biopharma Conference
02 Nov 2023 16:00:00 By Nasdaq GlobeNewswire